Evolent Health, Inc.
EVH
$2.99
-$0.07-2.29%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -27.50% | -22.83% | -31.34% | -24.39% | 16.27% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -27.50% | -22.83% | -31.34% | -24.39% | 16.27% |
| Cost of Revenue | -34.93% | -29.77% | -36.34% | -28.82% | 25.62% |
| Gross Profit | 28.45% | 23.65% | -6.04% | -1.57% | -25.50% |
| SG&A Expenses | 31.65% | 19.26% | 10.16% | 11.54% | 4.89% |
| Depreciation & Amortization | 485.20% | -20.49% | -22.53% | -18.46% | -74.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -23.53% | -24.43% | -30.77% | -23.96% | 18.28% |
| Operating Income | -145.84% | 105.34% | -70.00% | -70.76% | -22.77% |
| Income Before Tax | -1,700.81% | 15.99% | -1,625.92% | -277.79% | 50.23% |
| Income Tax Expenses | -49.60% | 246.37% | -246.64% | 160.18% | 92.35% |
| Earnings from Continuing Operations | -1,781.99% | 9.82% | -1,346.68% | -273.95% | 31.75% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1,781.99% | 9.82% | -1,346.68% | -273.95% | 31.75% |
| EBIT | -145.84% | 105.34% | -70.00% | -70.76% | -22.77% |
| EBITDA | 32.42% | 68.45% | -37.51% | -32.96% | -55.36% |
| EPS Basic | -900.71% | 13.17% | -691.56% | -183.48% | -0.03% |
| Normalized Basic EPS | -285.81% | 25.70% | -355.83% | -2,449.28% | -27.96% |
| EPS Diluted | -900.71% | 13.17% | -691.56% | -183.48% | -0.03% |
| Normalized Diluted EPS | -285.81% | 25.70% | -355.83% | -2,449.28% | -27.96% |
| Average Basic Shares Outstanding | -2.97% | -0.69% | 1.04% | 1.03% | 1.27% |
| Average Diluted Shares Outstanding | -2.97% | -0.69% | 1.04% | 1.03% | 1.27% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 1.00% | 0.58% | -1.07% | 0.76% | -0.36% |